Literature DB >> 16614701

Cell-cell contact mediated signalling - no fear of contact.

R Schmidmaier1, P Baumann, G Meinhardt.   

Abstract

Cancer research with sole focus on the cancer cell and possibly growth factors cannot faithfully reproduce the environmental interaction, such as adhesion of tumor cells to e.g. stromal cells, which may determine the response of these tumors to therapy. Methodologically cell adhesion studies are often difficult since complete but careful detachment is the prerequisite for most signal transduction assays. We describe for the first time an alternative method for the co-incubation of multiple myeloma cells on long term primary bone marrow stromal cultures using the bone marrow stromal cell line HS-5. The methods are precisely described, advantages and disadvantages are discussed, and troubleshooting advises are given.

Entities:  

Mesh:

Year:  2006        PMID: 16614701

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  5 in total

1.  The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias.

Authors:  Robert O'Connor; Melissa G Ooi; Justine Meiller; Jana Jakubikova; Steffen Klippel; Jake Delmore; Paul Richardson; Kenneth Anderson; Martin Clynes; Constantine S Mitsiades; Peter O'Gorman
Journal:  Cancer Chemother Pharmacol       Date:  2013-04-16       Impact factor: 3.333

2.  Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib.

Authors:  T Ishii; T Seike; T Nakashima; S Juliger; L Maharaj; S Soga; S Akinaga; J Cavenagh; S Joel; Y Shiotsu
Journal:  Blood Cancer J       Date:  2012-04-27       Impact factor: 11.037

3.  Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model.

Authors:  Alessandro Natoni; Mariah L Farrell; Sophie Harris; Carolyne Falank; Lucy Kirkham-McCarthy; Matthew S Macauley; Michaela R Reagan; Michael O'Dwyer
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

4.  Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.

Authors:  Jahangir Abdi; Nasrin Rastgoo; Yan Chen; Guo An Chen; Hong Chang
Journal:  BMC Cancer       Date:  2019-10-21       Impact factor: 4.430

5.  Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells.

Authors:  Xin-Yan Pei; Yun Dai; Jessica Felthousen; Shuang Chen; Yukie Takabatake; Liang Zhou; Leena E Youssefian; Michael W Sanderson; Wesley W Bodie; Lora B Kramer; Robert Z Orlowski; Steven Grant
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.